Sofinnova Venture Partners X L.P. 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-20 8:56 pm Sale |
2023-06-14 | 13D | Karuna Therapeutics, Inc. KRTX |
Sofinnova Venture Partners X L.P. | 1,439,649 3.800% |
-386,975 (-21.19%) |
Filing |
| 2023-02-03 7:11 pm Purchase |
2023-01-12 | 13D | Karuna Therapeutics, Inc. KRTX |
Sofinnova Venture Partners X L.P. | 1,826,624 5.300% |
97,272 (+5.62%) |
Filing |